Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics Inc. (DMAC) Income from Continuing Operations (2018 - 2019)

DiaMedica Therapeutics (DMAC) has 2 years of Income from Continuing Operations data on record, last reported at 2480000.0 in Q4 2019.

  • For Q4 2019, Income from Continuing Operations fell 26.34% year-over-year to 2480000.0; the TTM value through Dec 2019 reached 10649000.0, down 85.72%, while the annual FY2024 figure was 24444000.0, 26.12% down from the prior year.
  • Income from Continuing Operations reached 2480000.0 in Q4 2019 per DMAC's latest filing, down from 2448000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 650000.0 in Q1 2018 and bottomed at 3252000.0 in Q1 2019.